Proteomic Analysis of NULISA™ plasma analytes and Associations with Neurocognitive measures and Incident Dementia in older adults
Proteomanalyse von NULISA™-Plasmaanalyten und Zusammenhänge mit neurokognitiven Maßen und inzidenter Demenz bei älteren Erwachsenen
Alzheimer's & Dementia · 2025-12 · 21 (S8)
DOI: 10.1002/alz70862_110194 ↗Auf einen Blick
In 116 ARIC-Teilnehmenden waren einzelne NULISA™-Proteine mit Kognition und inzidenter Demenz assoziiert. Growth differentiation factor 15 war das einzige Protein mit Bezug zu inzidenter Demenz.
Fragestellung
Welche Zusammenhänge bestehen zwischen NULISA™-Plasma-Biomarkern, kognitiver Leistung und inzidenter Demenz bei älteren Erwachsenen?
Methode
Analyse von 116 ARIC-Teilnehmenden mit Plasmaproben; NULISA™ CNS 126 protein platform; lineare Regression und Cox-Modelle mit Anpassung auf Alter, Geschlecht, APOE ε4, Bildung und eGFR; FWE-Korrektur.
Ergebnisse
Von 126 Proteinen war Growth differentiation factor 15 mit inzidenter Demenz assoziiert (β = 4,7; p < 0,001). CD63 (β = -0,43; p < 0,001) und Eotaxin CCL11 (β = -0,37; p < 0,001) waren mit globaler Kognition assoziiert.
Einschränkungen
Die Autor:innen nennen eine begrenzte Power zur Bewertung des vollen Proteinspektrums.
Schlussfolgerung der Autor:innen
Proteine mit Funktionen in synaptischer Vesikelsekretion und Entzündung waren mit Kognition und inzidenter Demenz assoziiert; die Power war jedoch begrenzt.
Kernaussagen
- GDF15 war das einzige Protein mit Bezug zu inzidenter Demenz
- CD63 und Eotaxin CCL11 waren mit globaler Kognition assoziiert
- Keine signifikanten Zusammenhänge mit Sprach- oder Gedächtniswerten
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 23.12.2025. Verfasst von Joshua L Gills und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Gerontologische Pflege, Demenz
Abstract (Originalsprache)
Background
Neurodegenerative diseases, including Alzheimer's disease (AD), are characterized by progressive cognitive decline, with plasma biomarkers potentially playing a key role in early detection and risk assessment. The Nucleic Acid–Linked Immuno‐Sandwich Assay (NULISA™) offers high sensitivity for measuring low‐abundance proteins associated with AD pathology, including Aβ42/Aβ40, p ‐tau isoforms, NfL, and GFAP. We examined the associations between NULISA™‐quantified plasma biomarkers and cognitive performance and investigated their predictive value for incident dementia in older adults.
Method
This study utilized data from 116 ARIC cohort participants with available plasma samples. Plasma biomarkers were quantified using the NULISA™ CNS 126 protein platform. ATN & I biomarkers included: A (Aβ proteinopathy) – Aβ‐42, Aβ‐40, and Aβ‐42/40; T (phosphorylated and secreted AD tau) ‐ p ‐tau217, p ‐tau181, p ‐tau231 and their ratios with Aβ‐42; N (neuropil injury) – NfL and Total Tau; and I (inflammation) – GFAP. Cognitive performance was assessed using global and domain‐specific neurocognitive tests, and incident dementia cases were identified through longitudinal follow‐up. Linear regression and Cox proportional hazards models were used to examine biomarker associations with baseline cognition and dementia risk, adjusting for age, sex, APOE ε4 status, education, and glomerular filtration rate. FWE correction was utilized for multiple comparison adjustments.
Result
The 116 participants were on average 74.3 ± 4.7 years old, 88.8% were cognitively normal, 29.7% were APOE4 carriers, and overweight (BMI=29.7 ± 5.5 kg/m^2). Of the NULISA Alamar 126 proteins, Growth differentiation factor 15 was the only protein associated with Incident Dementia (β = 4.7, p < 0.001). Antigen CD63 (β = ‐0.43, p < 0.001) and Eotaxin CCL11 (β = ‐0.37, p < 0.001) were associated with global cognition. Growth Regulated Alpha Protein CXCL1 was associated with executive function (β = ‐0.33, p < 0.001). No significant relationships were identified between NULISA Alamar 126 proteins and language or memory scores.
Conclusion
Proteins subserving functions related to synaptic vesicle exocytosis and inflammation were associated with cognition and incident dementia in the ARIC sample, but power is limited to evaluate the full range of proteins. Future investigations should increase the sample size to identify other novel proteomic pathways related to cognition and incident dementia.
Zitieren
APA
Gills, J. L., Leo, H., & Bubu, O. M. (2025). Proteomic Analysis of NULISA™ plasma analytes and Associations with Neurocognitive measures and Incident Dementia in older adults. Alzheimer's & Dementia, 21(S8). https://doi.org/10.1002/alz70862_110194
Vancouver
Gills JL, Leo H, Bubu OM. Proteomic Analysis of NULISA™ plasma analytes and Associations with Neurocognitive measures and Incident Dementia in older adults. Alzheimer's & Dementia. 2025;21(S8). doi:10.1002/alz70862_110194
BibTeX
@article{Gills2025,
author = {Gills, Joshua L and Leo, Hubert and Bubu, Omonigho M},
title = {Proteomic Analysis of NULISA™ plasma analytes and Associations with Neurocognitive measures and Incident Dementia in older adults},
journal = {Alzheimer's & Dementia},
year = {2025},
volume = {21},
number = {S8},
doi = {10.1002/alz70862_110194}
}
EUVIMED